In a preclinical study on murine melanoma models, estrogen signalling through estrogen receptor alpha (ERα) promotes the polarization of TAMs toward an immunosuppressive M2 phenotype, which impairs cytotoxic T-cell function and limits ICI efficacy. The gene discussed is ESR1; the disease is melanoma.